
Photo from Raffaele Colombo/X
Nov 4, 2023, 00:58
Raffaele Colombo: Here the breakdown of the Monomethyl auristatin E Antibody Drug Conjugates
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X/Twitter:
106 auristatin Antibody Drug Conjugates (ADCs) have reached clinic development, of which two-thirds (= 71 ADC) with Monomethyl auristatin E (MMAE) as payload! Here the breakdown of the MMAE ADCs:
- 4 approved by FDA
- 1 approved by the National Medical Products Administration in China
- 41 in clinical development
- 25 discontinued
The MMAE history:
Source: Raffaele Colombo/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10
Feb 22, 2025, 13:04
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22
Feb 22, 2025, 11:15
Feb 22, 2025, 11:02